Ziel
Protein aggregation is a hallmark of many late onset neurodegenerative disorders including Parkinson’s Disease (PD), Alzheimer’s Disease (AD), amyotrophic lateral sclerosis (ALS), prion diseases as well as the group of polyglutamine diseases (polyQ). The aim of this proposal is to create a network of European partners bridging important basic mechanisms involved in proteinopathies, research of model diseases and treatment approaches. The “TreatPolyQ” network will focus on two main representatives of the polyQ diseases: Huntington’s disease as the most common polyQ disease as well as spinocerebellar ataxia type 3 (SCA3) as the most frequent autosomal-dominantly inherited ataxia. Patients suffer from a multitude of neurological symptoms including movement abnormalities with late onset and in a progressive manner. Up to now, no treatment or cure is available. The network will be consisting of a rare combination of experts from basic and translational research, including a Nobel prize laureate, four industrial partners (two medium, and two small companies, all incorporated as full participants) and academic leaders of the field. The network not only focuses on one special aspect of a disease but spans several important disease-associated mechanism as well as promising treatment strategies for HD and SCA3 (protein transport, protein folding, protein degradation via both the ubiquitin-proteasome system and autophagy), likely to be important across a range of neurodegenerative diseases. In order to implement these research projects, extensive collaborations and temporarily personnel secondments of the involved researchers will take place, enhancing interdisciplinary transfer of knowledge. Beyond the personalized local training plan for each employed researcher within the Network, there will be 4 structured courses covering aspects ranging from structural biology to protein degradation to model organisms and drug development, including soft skill training.
Wissenschaftliches Gebiet
- medical and health sciencesbasic medicinepharmacology and pharmacydrug discovery
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsprotein folding
- medical and health sciencesbasic medicineneurologyparkinson
- medical and health sciencesbasic medicineneurologyamyotrophic lateral sclerosis
Aufforderung zur Vorschlagseinreichung
FP7-PEOPLE-2010-ITN
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
MC-ITN - Networks for Initial Training (ITN)Koordinator
72074 Tuebingen
Deutschland
Auf der Karte ansehen
Beteiligte (15)
80539 Munchen
Auf der Karte ansehen
75231 Paris
Auf der Karte ansehen
Beteiligung beendet
2100 COPENHAGEN
Auf der Karte ansehen
17177 Stockholm
Auf der Karte ansehen
75794 Paris
Auf der Karte ansehen
32000 Haifa
Auf der Karte ansehen
CB2 1TN Cambridge
Auf der Karte ansehen
1015 Lausanne
Auf der Karte ansehen
3004 517 Coimbra
Auf der Karte ansehen
WC2R 2LS London
Auf der Karte ansehen
53100 SIENA
Auf der Karte ansehen
2500 Valby
Auf der Karte ansehen
F-75205 / 13 Paris
Auf der Karte ansehen
22100 LUND
Auf der Karte ansehen
Beteiligung beendet
2750 BALLERUP
Auf der Karte ansehen